The FDA approved Mylan’s Estradiol Vaginal Cream USP 0.01%, the first generic version of Allergan’s Estrace.
The United States should take action to reduce demand for the drugs fueling its deadly opioid crisis, a top Chinese drug control official said.
About 8.7 million people enrolled in healthcare plans for 2018 using the federal Obamacare marketplace, according to updated government figures.
Vetter Pharma – a Germany-based contract company specializing in aseptic filling and packaging of drugs into syringes, vials and cartridges – broke ground on its U.S. headquarters in Des Plaines, Illinois.
Todd Campbell, writing for The Motley Fool, notes four biopharma stocks that topped out in the S&P 500 in 2017.
The U.S. Food and Drug Administration issued a warning letter to Fresenius Kabi AG of Germany for its plant in India.
Here are five companies looking at possible drug approvals in January 2018.
GW Pharmaceuticals plc announced that the U.S. FDA accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for Epidiolex (cannabidiol or CBD) as an investigational treatment for seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome.
Male physicians in the U.S. – across almost every specialty – took in more money from the biomedical industry in 2015 than their female peers, a new study suggests.
The Wall Street Journal reported that Theranos Inc. secured a loan from Fortress Investment Group.
Array BioPharma spun off some intellectual property and equipment into a new company, Yarra Therapeutics.
Are marketers just paying lip service to the idea that the patient is in charge when it comes to developing patient acquisition and support programs?
Teva Pharmaceutical Industries Ltd. announced the exclusive launch of a generic version of Reyataz (atazanavir) capsules in the U.S.
Odonate Therapeutics Inc. announced that it has initiated CONTESSA, a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with locally advanced or metastatic breast cancer.
Anika Therapeutics Inc. announced that its HA-based bone void filler received 510(k) clearance from the U.S. FDA and is indicated for filling bone voids or defects of the skeletal system, which are not intrinsic to the stability of the bone, created during surgery or resulting from traumatic injury.
GenScript Biotech Corp. – a leading global provider of gene synthesis services – announced an agreement to acquire 100 percent of the issued shares of CustomArray Inc., a privately held DNA microarray company.
Sun Pharmaceutical Industries Ltd. announced the U.S. FDA accepted a New Drug Application (NDA) for OTX-101 (cyclosporine A, ophthalmic solution) 0.09%.
Older adults who take vitamin D and calcium are no less likely to break their hips or other bones than peers who do not use these supplements per a research review.
Mallinckrodt plc will acquire Sucampo Pharmaceuticals Inc., including its commercial and development assets.
Alexion Pharmaceuticals Inc. announced that the MHLW in Japan approved Soliris (eculizumab) as a treatment for patients with generalized myasthenia gravis.